Steris (STE) Cash from Investing Activities (2018 - 2026)

Steris' (STE) quarterly Cash from Investing Activities came in at -$217.2 million in Q1 2026, down 211.17% year-on-year from $195.4 million in Q1 2025, and down 120.51% quarter-over-quarter from -$98.5 million in Q4 2025.

Steris (STE) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Steris' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$217.2 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 211.17% year-over-year to -$217.2 million in Q1 2026; TTM through Mar 2026 was -$512.5 million, a 231.82% decrease from a year earlier, with the FY2026 full-year figure at -$512.5 million, down 231.82% from the prior year.
  • Cash from Investing Activities eased to -$217.2 million in Q1 2026 per STE's latest filing, from -$98.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $687.8 million in Q2 2024 and bottomed at -$606.2 million in Q3 2023.
  • The 5-year median for Cash from Investing Activities is -$98.4 million (2022), against an average of -$76.5 million.
  • Across the five-year window, Cash from Investing Activities tumbled 519.08% in 2023 and soared 1132.79% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$98.4 million in 2022, then retreated by 20.84% to -$118.9 million in 2023, then dropped by 4.19% to -$123.9 million in 2024, then advanced by 20.5% to -$98.5 million in 2025, then sank by 120.51% to -$217.2 million in 2026.
  • Per Business Quant, the three latest STE Cash from Investing Activities figures stand at -$217.2 million (Q1 2026), -$98.5 million (Q4 2025), and -$88.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.40 Bn 176.11 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.93 Bn 126.05 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.35 Bn 99.13 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.71 Bn 67.25 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.35 Bn 44.68 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.37 Bn 27.25 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 28.04 Bn 25.76 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.90 Bn 26.33 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn -475.32 Mn
10 Steris 21.44 Bn 21.00 Bn 697.10 Mn -217.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -217.20 Mn
Mar 31, 2026 -217.20 Mn
Dec 31, 2025 -98.50 Mn
Dec 31, 2025 -98.50 Mn
Sep 30, 2025 -88.30 Mn
Sep 30, 2025 -88.30 Mn
Jun 30, 2025 -108.50 Mn
Jun 30, 2025 -108.50 Mn
Mar 31, 2025 -69.80 Mn
Mar 31, 2025 -69.80 Mn
Dec 31, 2024 -123.90 Mn
Dec 31, 2024 -123.90 Mn
Sep 30, 2024 -105.30 Mn
Sep 30, 2024 -105.30 Mn
Jun 30, 2024 687.80 Mn
Jun 30, 2024 687.80 Mn
Mar 31, 2024 -95.65 Mn
Mar 31, 2024 -95.65 Mn
Dec 31, 2023 -118.92 Mn
Dec 31, 2023 -118.92 Mn